Cargando…
2095 Drug screening and hit identification for night blindness with zebrafish
OBJECTIVES/SPECIFIC AIMS: Retinitis pigmentosa (RP), also known as night blindness, is an incurable disease which affects ~1 in 4000 individuals globally. Since there are no effective treatment options for RP, the goal of this project is to identify novel drug treatments that can prevent or slow the...
Autores principales: | Ganzen, Logan, Leung, Yuk Fai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799665/ http://dx.doi.org/10.1017/cts.2018.69 |
Ejemplares similares
-
2217: A transgenic retinitis pigmentosa zebrafish model for drug discovery
por: Ganzen, Logan, et al.
Publicado: (2018) -
3571 Expression profile of the ribbon synapse protein Ribeye in the zebrafish
por: Frederick, Courtney, et al.
Publicado: (2019) -
2525 Development of human cell-based screening assays to detect subject-specific drug-response variability
por: Stillitano, Francesca, et al.
Publicado: (2018) -
Utilizing Zebrafish Visual Behaviors in Drug Screening for Retinal Degeneration
por: Ganzen, Logan, et al.
Publicado: (2017) -
3444 Development of human engineered cardiac tissue (hECT)-based screening assay to explore cardiac contractile properties in response to pharmacological challenge with proarrhythmic drugs
por: Stillitano, Francesca, et al.
Publicado: (2019)